Bismuth-Based Therapy: The New Therapy for Obese Patients Undergoing Gastric Bypass Surgery?
ConclusionTen days of BQT did achieve Maastricht V/Florence recommended first-line eradication rates (at least 80%) in obese Portuguese patients undergoing Roux-en Y gastric bypass, being by now the most reliable choice for Hp eradication.Graphical Abstract
Source: Obesity Surgery - Category: Surgery Source Type: research
More News: Biaxin | Clarithromycin | Eating Disorders & Weight Management | Endoscopy | Gastric Bypass | Gastroenterology | Metronidazole | Obesity | Portugal Health | Proton Pump Inhibitors PPIs | Smokers | Statistics | Study | Surgery | Tetracycline